MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
81 hedge funds and large institutions have $139M invested in Marinus Pharmaceuticals, Inc in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 19 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
Holders
81
Holding in Top 10
2
Calls
$5.87M
Puts
$5.96M
Top Buyers
| 1 | +$3.18M | |
| 2 | +$2.28M | |
| 3 | +$1.83M | |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$1.61M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.1M |
Top Sellers
| 1 | -$4.88M | |
| 2 | -$1.79M | |
| 3 | -$1.51M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$1.44M |
| 5 |
Millennium Management
New York
|
-$906K |